SUSAN MANGUM: Open Payments
NPI 1962657486 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 64 payments from 15 companies in 2025. Trend: 2023 $928 · 2024 $1,033 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $390 |
| AstraZeneca Pharmaceuticals LP | 9 | $251 |
| Amgen Inc. | 10 | $152 |
| ABBVIE INC. | 6 | $135 |
| SHIELD THERAPEUTICS INC | 4 | $81 |
| ALK-Abello, Inc | 2 | $64 |
| PFIZER INC. | 2 | $44 |
| Dexcom, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: Kerendia, OTEZLA, BREZTRI, FARXIGA, ACCRUFER, Grastek, VRAYLAR, PAXLOVID.
Industry payments across TX — which companies pay providers there.
